Papillary Phenotype Confers Improved Survival After Resection of Hilar Cholangiocarcinoma

William R. Jarnagin(Memorial Sloan Kettering Cancer Center), Wilbur B. Bowne(Memorial Sloan Kettering Cancer Center), David S. Klimstra(Memorial Sloan Kettering Cancer Center), Leah Ben‐Porat(Memorial Sloan Kettering Cancer Center), Kevin K. Roggin(Memorial Sloan Kettering Cancer Center), Karína Cymes(Memorial Sloan Kettering Cancer Center), Yuman Fong(Memorial Sloan Kettering Cancer Center), Ronald P. DeMatteo(Memorial Sloan Kettering Cancer Center), Michael D Angelica(Memorial Sloan Kettering Cancer Center), Jonathan Koea(Memorial Sloan Kettering Cancer Center), Leslie H. Blumgart(Memorial Sloan Kettering Cancer Center)
Annals of Surgery
April 19, 2005
Cited by 194Open Access
Full Text

Abstract

OBJECTIVE: The current study compares outcome after resection of papillary hilar cholangiocarcinoma to that of the more common nodular-sclerosing subtype. METHODS: Clinical, radiologic, histopathologic, and survival data on all patients with hilar cholangiocarcinoma were analyzed. Resected tumors were reexamined and classified as nodular-sclerosing (no component of papillary carcinoma) or papillary (any component of papillary carcinoma); for papillary tumors, the proportion of invasive carcinoma present was determined. Differences in the clinical behavior and histopathologic features of nodular-sclerosing and papillary tumors were assessed. RESULTS: From January 1991 to November 2003, 279 patients were evaluated, 154 men (55.2%) and 125 women (44.8%), with a mean age of 65.4 +/- 0.7 years (median = 68, range 23-87 years). Of the 215 patients explored, 106 (49.5%) underwent a complete gross resection. An en bloc partial hepatectomy (n = 87) and an R0 resection (n = 82) were independent predictors of favorable outcome. Operative mortality was 7.5% but was 2.8% over the last 4 years of the study, and there were no operative deaths in the last 33 consecutive resections. Twenty-five resected tumors (23.6%) contained a papillary component: 12 were minimally or noninvasive (<10% invasive cancer) and 13 had an invasive component ranging from 10% to 95% (> or =10%). Patients with papillary and nodular-sclerosing tumors had similar demographics, operative procedures, and proportion of R0 resections. By contrast, papillary tumors were significantly larger, more often well-differentiated, and earlier stage. Disease-specific survival after resection of papillary tumors (55.7 months) was greater than after resection of nodular-sclerosing lesions (33.5 months, P = 0.013). The papillary phenotype was an independent predictor of survival, although the benefit was more pronounced for less invasive tumors. CONCLUSIONS: The presence of a component of papillary carcinoma is more common than previous reports have suggested and is an important determinant of survival after resection of hilar cholangiocarcinoma.


Related Papers

No related papers found

Powered by citation graph analysis